“People opposed to China’s stringent Covid restrictions have protested in cities across the country in the biggest wave of civil disobedience on the mainland since Xi Jinping assumed power a decade ago.” [Source: theguardian.com]
Watching China’s increasingly authoritarian approach to the control of COVID-19 it is easy to forget that, early in the pandemic, its doctors had led the world in their pioneering use of high-dose vitamin C to fight the viral outbreak.
As early as March 2020, a medical team from the Second Affiliated Hospital of Xi’an Jiaotong University had reported the successful treatment of coronavirus patients with vitamin C. In a press release posted on their hospital website, the team described how patients suffering from severe coronary pneumonia, a potentially fatal complication of COVID-19, had recovered after being treated with high doses of the vitamin. The medical team recommended that for critically ill patients and those with severe neonatal pneumonia, vitamin C treatment should be initiated as soon as possible after admission to hospital.
By October 2020, Chinese doctors had published a randomized, placebo-controlled clinical intervention study in patients at advanced stages of COVID-19. A multi-center clinical study coordinated by the University Hospital of Wuhan, the city at the center of the outbreak, its results documented unequivocally that high-dose vitamin C can cut the death rate from the virus almost in half.
Subsequent work carried out by scientists at the Dr. Rath Research Institute has established that a combination of vitamin C, N-acetylcysteine, and 7 specific plant extracts is highly effective in simultaneously inhibiting not only the original SARS-CoV-2 coronavirus but also its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. As such, together with the evidence that high-dose vitamin C can successfully combat COVID-19 even in its advanced stages, it is now clear that as a means of controlling the pandemic, the enforcement of draconian ‘zero Covid’ restrictions is unnecessary.